Related Experiment Video
Updated: Aug 15, 2025

An Orthotopic Resectional Mouse Model of Pancreatic Cancer
Published on: September 24, 2020
Ewing Sarcoma: Rare Metastasis to the Pancreas
Bhavna A Guduguntla1, Jiaqi Shi2, Richard S Kwon3
1University of Michigan Medical School, Ann Arbor, MI.
Ewing sarcoma is a rare but aggressive cancer. This case highlights a pancreatic metastasis initially misdiagnosed as small cell neuroendocrine carcinoma, emphasizing the need for thorough diagnostic evaluation.
Area of Science:
- Oncology
- Pathology
- Medical Imaging
Background:
- Ewing sarcoma is a highly aggressive bone and soft tissue cancer.
- Metastasis occurs in 20-25% of patients, commonly affecting bone, bone marrow, and lungs.
- Rare visceral metastases can mimic other malignancies, complicating diagnosis.
Observation:
- A 37-year-old man presented with metastatic Ewing sarcoma.
- The metastasis involved the pancreas, a rare site.
- Initial diagnosis was suspected small cell neuroendocrine carcinoma based on imaging.
Findings:
- Diagnostic workup included imaging, genetic sequencing, fluorescence in situ hybridization (FISH), and histology.
- Confirmation of metastatic Ewing sarcoma involving the pancreas was achieved.
- The pancreatic mass was initially misdiagnosed due to its rare location.
Implications:
- This case underscores the importance of considering rare metastatic patterns in Ewing sarcoma.
- Accurate diagnosis is crucial for appropriate treatment selection and patient management.
- Enhanced awareness of unusual presentations can prevent diagnostic delays and errors.
More Related Videos
12:07Laparoscopic Radical Antegrade Modular Pancreatosplenectomy via Dorsal-Caudal Artery Approach for Pancreatic Neck-Body Cancer
Published on: November 18, 2022
08:12Laparoscopic Pancreatoduodenectomy for Pancreatic Cancer Using In-Situ No-Touch Isolation Technique
Published on: February 2, 2022